AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials
U.K. drugmaker hopes to have the two-dose shot available for use around year-end, pending regulatory approval
AstraZeneca and the University of Oxford said their Covid-19 vaccine was as much as 90% effective in preventing infections without serious side effects in large clinical trials.
The AstraZeneca-Oxford vaccine stands out among the leading Western candidates. The partners committed to selling it without profit during the pandemic and promised to distribute it across a much wider geographic footprint, including in large parts of the developing world. The shot is expected to cost $3 to $5 a dose globally during the pandemic.
AstraZeneca said it would seek emergency-use authorization from the World Health Organization to distribute the vaccine in low-income countries and prepare regulatory submissions to authorities in countries that have early-approval programs.
China and Russia have both deployed their own vaccines at home and overseas. Chinese authorities have inoculated nearly one million Chinese people with a vaccine from one state company, though it has yet to provide solid clinical evidence of its efficacy. Russia has said its own homegrown vaccine has an efficacy rate of above 90%.https://www.wsj.com/articles/astraz...tage-trials-11606116047?mod=hp_lead_pos1